BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2956411)

  • 1. Effect of the binding of isradipine and darodipine to different plasma proteins on their transfer through the rat blood-brain barrier. Drug binding to lipoproteins does not limit the transfer of drug.
    Urien S; Pinquier JL; Paquette B; Chaumet-Riffaud P; Kiechel JR; Tillement JP
    J Pharmacol Exp Ther; 1987 Jul; 242(1):349-53. PubMed ID: 2956411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats.
    Urien S; Morin D; Tillement JP
    J Pharmacol Exp Ther; 1989 Feb; 248(2):781-5. PubMed ID: 2918479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of plasma protein binding of bupivacaine on its in vivo transfer into the brain and salivary gland of rats.
    Terasaki T; Pardridge WM; Denson DD
    J Pharmacol Exp Ther; 1986 Dec; 239(3):724-9. PubMed ID: 3795038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone.
    Pardridge WM; Mietus LJ
    J Clin Invest; 1979 Jul; 64(1):145-54. PubMed ID: 447850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the binding of imipramine to erythrocytes and plasma proteins on its transport through the rat blood-brain barrier.
    Riant P; Urien S; Albengres E; Renouard A; Tillement JP
    J Neurochem; 1988 Aug; 51(2):421-5. PubMed ID: 3392536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of erythrocytes and plasma protein binding on the transport of progabide and SL 75102 through the rat blood-brain barrier.
    Hamberger C; Urien S; Essassi D; Grimaldi B; Barre J; Taiclet A; Thenot JP; Tillement JP
    Biochem Pharmacol; 1987 Aug; 36(16):2641-5. PubMed ID: 3606664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytes.
    Pinquier JL; Urien S; Lemaire M; Chaumet-Riffaud P; Tillement JP
    Pharmacology; 1988; 36(5):305-12. PubMed ID: 2457222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influx of thyroid hormones into rat liver in vivo. Differential availability of thyroxine and triiodothyronine bound by plasma proteins.
    Pardridge WM; Mietus LJ
    J Clin Invest; 1980 Aug; 66(2):367-74. PubMed ID: 6772672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the serum binding determinants of isradipine and darodipine--consequences for serum protein binding in various diseases.
    Pinquier JL; Urien S; Chaumet-Riffaud P; Tillement JP
    Br J Clin Pharmacol; 1989 Nov; 28(5):587-92. PubMed ID: 2531607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man and dog.
    Niwa T; Tokuma Y; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):75-88. PubMed ID: 3563108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective binding of isradipine to human plasma proteins.
    Oravcová J; Sojková D; Bencsíková E; Bohov P; Trnovec T
    Chirality; 1995; 7(3):167-72. PubMed ID: 7794694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of propranolol and lidocaine through the rat blood-brain barrier. Primary role of globulin-bound drug.
    Pardridge WM; Sakiyama R; Fierer G
    J Clin Invest; 1983 Apr; 71(4):900-8. PubMed ID: 6833493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-to-brain transfer of various oxicams: effects of plasma binding on their brain delivery.
    Jolliet P; Simon N; Brée F; Urien S; Pagliara A; Carrupt PA; Testa B; Tillement JP
    Pharm Res; 1997 May; 14(5):650-6. PubMed ID: 9165538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of blood components on the tissue uptake indices of cyclosporin in rats.
    Lemaire M; Pardridge WM; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Feb; 244(2):740-3. PubMed ID: 3346845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of serum protein binding of felodipine.
    Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing isradipine and amlodipine binding to human plasma lipoproteins.
    Oravcova J; Sojkova D; Fetkovska N; Trnovec T
    Blood Press Suppl; 1994; 1():61-4. PubMed ID: 8205304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantioselective plasma protein binding of bimoclomol.
    Visy J; Fitos I; Mády G; Urge L; Krajcsi P; Simonyi M
    Chirality; 2002 Aug; 14(8):638-42. PubMed ID: 12125033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of cyclosporine A interactions with human plasma lipoproteins in vitro and in vivo in the rat.
    Urien S; Zini R; Lemaire M; Tillement JP
    J Pharmacol Exp Ther; 1990 Apr; 253(1):305-9. PubMed ID: 2329513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased blood--brain barrier transport of protein-bound anticonvulsant drugs in the newborn.
    Cornford EM; Pardridge WM; Braun LD; Oldendorf WH
    J Cereb Blood Flow Metab; 1983 Sep; 3(3):280-6. PubMed ID: 6874737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.